Cabometyx (cabozantinib tablets) — Cigna
Gastrointestinal Stromal Tumors
Initial criteria
- Patient age ≥ 18 years
- Patient has tried ALL of the following: imatinib or Ayvakit (avapritinib tablets); AND sunitinib or Sprycel (dasatinib tablets); AND Stivarga (regorafenib tablets); AND Qinlock (ripretinib tablets)
Approval duration
1 year